Circulating exosomes may provide a more sensitive platform to monitor disease progression compared to circulating tumor cells.Traci Pawlowski, Christine Kuslich, Tingming Deng et al.|Journal of Clinical Oncology|2010Cited by 2
A sensitive exosome-based biosignature for the diagnosis of prostate cancer.Christine Kuslich, David Spetzler, Traci Pawlowski et al.|Journal of Clinical Oncology|2010Cited by 0